Post by Inpharmus

In clinical oncology, the key barrier is not the lack of data, but its interpretation.   Healthcare systems are increasingly “data rich, information poor.” High statistical reliability can mask clinicalvariability. The same evidence can lead to different policy decisions. And genomic data often remains a grayzone in practice.   The focus must shift from generating more data to standardizing how we interpret it. Real-world evidenceand multidisciplinary alignment are critical to turning data into meaningful outcomes.   #Inpharmus #Oncology #MedicalStrategy #DataScience #RealWorldEvidence